Leuprolide Acetate 3.75 mg Depot Injection

leuprolide acetate · Bharat Serums and Vaccines Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Leuprolide Acetate 3.75 mg Depot Injection, covering 2023-08-01 to 2023-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer [Phase 3]